| Profil: |
Nipro Corporation is a Japanese medical equipment manufacturing company founded in 1954 and headquartered in Osaka. It specializes in the development, production, and sale of medical devices, pharmaceuticals, and pharmaceutical packaging solutions, operating through key segments including medical-related products, pharmaceutical-related products, pharma packaging, and others. The medical portfolio encompasses dialysis systems, vascular access and intervention products, injection and infusion systems, diagnostic tools, diabetes care items, and artificial organ products, alongside generic drugs, kit pharmaceuticals, and glass packaging like vials, ampoules, and syringes. With manufacturing facilities in Japan, India, China, Thailand, Brazil, and beyond, Nipro Corporation maintains a global footprint across Asia, Europe, and the Americas, employing approximately 39,000 people worldwide. Its diverse offerings support hospitals, clinics, pharmacies, and healthcare providers, emphasizing renal care, infusion therapy, in-vitro diagnostics, and regenerative medicine initiatives. Listed on the Tokyo Stock Exchange's Prime Market, Nipro Corporation plays a vital role in advancing medical technology and pharmaceutical supply chains internationally.
>einklappen..
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
